Senseonics Holdings, Inc. (SENS)
9.90
-0.04
(-0.40%)
USD |
NASDAQ |
Sep 03, 16:00
9.73
-0.17
(-1.72%)
After-Hours: 07:29
Senseonics Holdings Research and Development Expense (Annual) : 31.59M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 31.59M |
| December 31, 2024 | 41.14M |
| December 31, 2023 | 48.75M |
| December 31, 2022 | 39.72M |
| December 31, 2021 | 27.22M |
| December 31, 2020 | 20.41M |
| Date | Value |
|---|---|
| December 31, 2019 | 38.43M |
| December 31, 2018 | 31.86M |
| December 31, 2017 | 30.74M |
| December 31, 2016 | 26.35M |
| December 31, 2015 | 18.25M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Electromed, Inc. | 1.314M |
| Tandem Diabetes Care, Inc. | 174.84M |
| Accuray, Inc. | 37.75M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 65.85M |